COPD Connect
  • Saved

The manifestation of Pasteurella multocida pneumonia in a patient with COPD underscores the necessity of clinical vigilance toward atypical pathogens when conventional treatment approaches yield suboptimal responses.

  • Saved

Among 553 patients with COPD, β-blocker prescription at hospital discharge was not associated with increased risk of mortality or adverse cardiopulmonary outcomes.

  • Saved
Herbaspirillum Seropedicae Bacteremia Secondary to Pneumonia in a Patient With Chronic Obstructive Pulmonary Disease

Herbaspirillum Seropedicae Bacteremia Secondary to Pneumonia in a Patient With Chronic Obstructive Pulmonary Disease

Source : https://www.cureus.com/articles/248742-herbaspirillum-seropedicae-bacteremia-secondary-to-pneumonia-in-a-patient-with-chronic-obstructive-pulmonary-disease

Herbaspirillum seropedicae is a species of bacteria commonly found in vegetation, but in rare cases, can cause opportunistic infections in human hosts. Infections typically occur due to environmental exposure to...

The patient’s COPD, environmental exposure through gardening, and the use of immunosuppressive inhaled corticosteroids were identified as predisposing factors for Herbaspirillum infection.

  • Saved
Racial Differences in 1-Year Mortality After Hospitalization for Chronic Obstructive Pulmonary Disease in the United States

Racial Differences in 1-Year Mortality After Hospitalization for Chronic Obstructive Pulmonary Disease in the United States

Source : https://pubmed.ncbi.nlm.nih.gov/37943953/

Rationale: One quarter of Medicare beneficiaries hospitalized for chronic obstructive pulmonary disease (COPD) die within 1 year. Although overall mortality rates are higher among White patients with COPD, racial and...

Medicare beneficiaries of racial and ethnic minority groups had a lower risk of dying within 1 year of hospitalization than those who were White.